Lp(a) Measurement by Electrophoresis and Immunofixation Electrophoresis for Assessment of Cardiovascular Risk

Wednesday, July 27
6 – 7:30 p.m.
Hyatt Regency, Regency Ballroom CD
Sponsored by Helena Laboratories

Overview

Helena Laboratories lipoprotein electrophoresis methods allow for separation of lipoproteins Lp(a), LDL, HDL, VLDL, and IDL, as well as subsequent quantitative measurement of cholesterol and triglyceride components of each lipoprotein using enzymatic staining and measurement of Lp(a)-P and other lipoprotein particles (e.g., LDL-P, IDL-P and VLDL-P) by immunofixation with anti-apoB antisera.

Outcomes

After attending this session, participants will be able to:

  • Understand how the electrophoretic measurements are not influenced by apo(a) isoform size, allowing true apo(a) isoform independent measurement of Lp(a).

Moderator 

Robert S. Galen, MD, MPH
Professor Emeritus, College of Public Health - University of Georgia
Athens, GA

Speakers

Robert S. Galen, MD, MPH
Professor Emeritus, College of Public Health - University of Georgia
Athens, GA

Joseph McConnell, MD
Sr. Vice President, Aditxt Therapeutics, Inc.
Richmond, VA

Szilard Voros, MD
Sr. Vice President